News Incyte Corporation

Equities

INCY

US45337C1027

Market Closed - Nasdaq Other stock markets 04:00:02 2024-05-01 pm EDT			5-day change	1st Jan Change
52.92 ^USD	+1.68%		+2.47%	-15.71%

05:34pm	TD Cowen Adjusts Price Target on Incyte to $80 From $88	MT
04:54pm	RBC Capital Adjusts Price Target on Incyte to $60 From $65	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TD Cowen Adjusts Price Target on Incyte to $80 From $88	11:34am	MT
RBC Capital Adjusts Price Target on Incyte to $60 From $65	10:54am	MT
Piper Sandler Adjusts Price Target on Incyte to $80 From $85	10:35am	MT
Goldman Sachs Adjusts Price Target on Incyte to $60 From $63	10:21am	MT
Leerink Partners Adjusts Price Target on Incyte to $80 From $83, Keeps Outperform Rating	08:56am	MT
Citigroup Adjusts Price Target on Incyte to $80 From $81	08:06am	MT
BMO Capital Adjusts Incyte Price Target to $52 From $56	07:55am	MT
Truist Securities Trims Incyte's Price Target to $83 From $84, Buy Rating Maintained	Apr. 30	MT
Incyte's Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed	Apr. 30	MT
Transcript : Incyte Corporation, Q1 2024 Earnings Call, Apr 30, 2024	Apr. 30
Earnings Flash (INCY) INCYTE Posts Q1 Revenue $880.9M, vs. Street Est of $924.6M	Apr. 30	MT
Earnings Flash (INCY) INCYTE Posts Q1 EPS $0.64, vs. Street Est of $0.83	Apr. 30	MT
Incyte: Q1 Earnings Snapshot	Apr. 30	AQ
Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs	Apr. 30	BU
Incyte Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 30	CI
Incyte Corporation Maintains Earnings Guidance for 2024	Apr. 30	CI
'Shadow Trading' Verdict A Reminder For Companies To Review Insider Trading Policies And Train Insiders	Apr. 29	AQ
SEC Secures Groundbreaking Win In Shadow Trading Insider Trading Case	Apr. 27	AQ
"Shadow Trading" Is Insider Trading: Jury Establishes Liability In Historic Shadow Trading Case	Apr. 24	AQ
Oppenheimer Adjusts Incyte Price Target to $84 From $92, Maintains Outperform Rating	Apr. 24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Incyte Corporation : Is a big change imminent?

October 26, 2023 at 10:00 am EDT